AI MARKET SCANNING

Maze Therapeutics Inc

📅 Next Catalyst: Nov 05, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -3.63%
MAX GAP RECORD -18.37%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $MAZE
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 05, 2026 Earnings Release 2026-11-05 (AFTER CLOSE (21:00)) 🔮 UPCOMING 🔒
Aug 18, 2026 Earnings Release 2026-08-18 (AFTER CLOSE)
+1.99%
Mar 25, 2026 Earnings Release 2026-03-25 (BEFORE OPEN)
-18.37%
Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE)
+0.81%
Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE)
+1.89%
Mar 31, 2025 Earnings Release 2025-03-31 (BEFORE OPEN)
-4.47%
Jan 31, 2025 Earnings Release 2025-01-31 (UNDETERMINED)
+0.00%

VOLATILITY & GAP BIAS

AVG GAP MOVE 5.5%
Bullish Gaps (2)
Bearish Gaps (2)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $MAZE

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-08-13 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1066m +1.34%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes the Compass platform, which allows it to identify and characterize genetic…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗